The Pharmacokinetics Study of Nanoparticles of Fe2O3 Coated with Glutamic Acid

Lan LIU,Meng TANG,Lu LIU,Qi-hua YIN,Bo WANG,Li-lin XIONG,Ning GU,Ming MA,Yu ZHANG
DOI: https://doi.org/10.3969/j.issn.1006-3617.2006.01.001
2006-01-01
Abstract:[ Objective] To explore the pharmacokinetics of nanoparticles of Fe2O3 coated with glutamic acid( nano-Fe2O3- Glu). [ Methods] 59Fe was used as a tracer to investigate the pharmacokinetics of nano-Fe2O3-Glu given via tail vein in mice. [Results] The time-concentration curve of nano-Fe2O3-Glu was fit mainly to a two-compartment model in mice. The equation was C=29.09e-4.29t+1.13e-0.009673t,T1/2,α=0.16 h,T1/2,β=71.65 h. Nano-Fe2O3-Glu was found to be distributed widely in various organs in vivo,and the concentration in liver and spleen was higher than that in other organs,cpmi/cpmj in liver was 48.93%(ID/g) at one hour after injection,the cpm0 in liver was 80.60% of total cpm in mice. Moreover,the time of peak concentration in various organs was different. [ Conclusion] The characteristics of pharmacokinetics are accordant to a two-compartment model. Nano- Fe2O3-Glu can permeate the blood barriers of brain,eyes and genitals,and its target organs may be liver and spleen.
What problem does this paper attempt to address?